Loading
Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes / Psychosomatic Disorders and Their Treatments / Treatment of Major Depression · Journal article
BMC Psychiatry · September 9, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a prospective study protocol for a planned multicenter RCT comparing 12 weeks of psychomotor therapy plus standard care versus standard care alone in adults with major depressive disorder. No outcomes have been measured or reported; this document outlines the intended design and analysis only, and therefore constitutes preliminary/hypothesis-generating work rather than evidence of effectiveness.
Multicenter, prospective, randomized controlled trial. Adults diagnosed with Major Depressive Disorder. Intervention: Psychomotor therapy (PMT) for 12 weeks in addition to standard care. Compared with: Standard care with weekly telephone follow-up. n = 128. Multicenter (specific sites not named in protocol excerpt).
This is a prospective study protocol for a planned multicenter RCT comparing 12 weeks of psychomotor therapy plus standard care versus standard care alone in adults with major depressive disorder. No outcomes have been measured or reported; this document outlines the intended design and analysis only, and therefore constitutes preliminary/hypothesis-generating work rather than evidence of effectiveness.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
As a protocol only, this paper does not yet support clinical decision-making. Once results are published, this trial could address an important gap by testing whether psychomotor therapy improves quality of life and psychomotor symptoms in depression; however, clinicians should await completion and peer-reviewed results before considering implementation.
This is a study protocol describing a planned RCT that has not yet reported results; it presents the design and intended analysis but no outcome data, making it a prospective registration document rather than a completed trial.
As stated by the source record.
Quoted from the source exactly as published.
As a protocol only, this paper does not yet support clinical decision-making. Once results are published, this trial could address an important gap by testing whether psychomotor therapy improves quality of life and psychomotor symptoms in depression; however, clinicians should await completion and peer-reviewed results before considering implementation.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Psychomotor disturbances, such as cognitive-motor and sensory deficits, are well documented in Major Depressive Disorder (MDD). Although they impact quality of life, they remain insufficiently assessed and targeted in clinical practice. Psychomotor therapy (PMT) appears promising for improving functioning and quality of life, but strong evidence from randomized controlled trials (RCT) in adults with MDD is still lacking. This multicenter, prospective RCT aims to assess the effectiveness of a PMT on the quality of life and psychomotor functioning in adults with MDD. 128 participants diagnosed with MDD will be randomized into either the intervention group (GP) or the control group (GC). The GP will receive 12-weeks of a PMT in addition to standard care, while the GC will receive standard care with a weekly telephone follow-up. Sociodemographic, clinical, and psychomotor data will be collected at baseline and then again at 1, 3, and 6 months to serve as primary and secondary outcome measures. These data will be used to evaluate improvements in quality of life, as well as changes in depressive and anxiety symptoms, psychomotor slowing, anhedonia, self-esteem, and overall psychomotor functioning, including body image, interoception, and sensory processing. Therapeutic alliance and adherence to the PMT will also be monitored throughout the intervention. This study is the first RCT assessing the benefits of PMT on the quality of life of MDD patients. This study could justify the prescription of PMT for patients with depression and support the inclusion of psychomotor therapists in multidisciplinary teams in adult psychiatry. ClinicalTrials.gov identifier: NCT06234176 on 2024–01-15
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.